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Background: Magnetic resonance imaging (MRI) is highly accurate for evaluation of heart size and structure. Left ventricular hypertrophy (LVH), defined 
from MRI derived left ventricular mass, has not been evaluated for its reclassification properties for coronary events in a large epidemiologic study.
methods: Multi-Ethnic study of Atherosclerosis (MESA) is a population based study (n=6,814) of White (38%), Black (28%), Chinese (22%) and 
Hispanic (12%) subjects, aged 45-84 years, free from clinical cardiovascular disease. We performed post-hoc analysis (N=4,921) of the limited 
access dataset to analyze association of LVH with all cardiovascular and hard coronary events. LVH was defined as the upper 95th percentile of left 
ventricular mass index (LV end-diastolic mass/body surface area (g/m2)) for males and females without hypertension (no use of antihypertensive 
medications, systolic blood pressure <140 mm Hg, diastolic blood pressure <90 mm Hg). Multivariate Cox proportional hazard analysis was 
performed to assess the independent association between LVH and study outcomes. Net reclassification index was calculated for models including 
traditional risk factors with and without LVH for hard coronary events.
results: See Table 1
conclusion: Although LVH is a strong independent predictor of cardiovascular events, it does not help in the reclassification of overall and 
intermediate risk population for future coronary events.
 
